Matinas BioPharma Holdings, Inc.

MTNB

$0.18

-2.69%

N/A-$0.01

Healthcare

Biotechnology

AMEX

Active Trading

Matinas BioPharma Holdings, Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to identifying and advancing a range of potential ...

Historical Employee Count of MTNB

Current

Change

-33.33%

Minimum

Maximum

Recent Filings

Report Date	Employees	Form Type	Filing Date	SEC Filing
Dec 31, 2025	2	10-K	Mar 31, 2026	View
Dec 31, 2024	3	10-K	Apr 15, 2025	View
Dec 31, 2023	32	10-K	Mar 27, 2024	View
Dec 31, 2022	34	10-K	Mar 15, 2023	View
Dec 31, 2021	31	10-K	Mar 8, 2022	View

Supply Chain of MTNB

Upstream / Downstream / Proxies

Upstream

National Resilience, Inc.BioNTech SENASDAQ:BNTXNIH / NIAID (National Institutes of Health)Contract Research Organizations (CROs)Lipid / Phospholipid Excipient ManufacturersAmphotericin B API Manufacturers

Downstream

BioNTech SENASDAQ:BNTXProspective MAT2203 Licensee (Terminated)

Proxies

BioNTech SENASDAQ:BNTXEvonik Industries AGETR:EVKLonza Group AGSWX:LONN

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer